PPA
RGNX icon

Parametric Portfolio Associates’s Regenxbio RGNX Stock Holding History

Parametric Portfolio Associates’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$2.73M Sell
82,347
-22,711
-22% -$631K ﹤0.01% 2250
2021
Q4 		$3.44M Buy
105,058
+25,233
+32% +$859K ﹤0.01% 2107
2021
Q3 		$3.35M Buy
79,825
+6,307
+9% +$227K ﹤0.01% 2109
2021
Q2 		$2.86M Buy
73,518
+17,063
+30% +$610K ﹤0.01% 2220
2021
Q1 		$1.93M Buy
56,455
+11,749
+26% +$501K ﹤0.01% 2801
2020
Q4 		$2.03M Buy
44,706
+21,667
+94% +$757K ﹤0.01% 2641
2020
Q3 		$634K Sell
23,039
-25,341
-52% -$826K ﹤0.01% 3157
2020
Q2 		$1.78M Buy
48,380
+15,901
+49% +$593K ﹤0.01% 2566
2020
Q1 		$1.05M Sell
32,479
-8,433
-21% -$351K ﹤0.01% 2768
2019
Q4 		$1.68M Buy
40,912
+20,704
+102% +$818K ﹤0.01% 2800
2019
Q3 		$719K Sell
20,208
-8,261
-29% -$335K ﹤0.01% 3197
2019
Q2 		$1.46M Sell
28,469
-17,903
-39% -$894K ﹤0.01% 2851
2019
Q1 		$2.66M Buy
46,372
+18,806
+68% +$932K ﹤0.01% 2478
2018
Q4 		$1.16M Sell
27,566
-651
-2% -$38.2K ﹤0.01% 2891
2018
Q3 		$2.13M Sell
28,217
-14,925
-35% -$1.08M ﹤0.01% 2669
2018
Q2 		$3.1M Buy
+43,142
New +$2.06M ﹤0.01% 2356
2017
Q3 		– Sell
-40,935
Closed -$808K – 4048
2017
Q2 		$808K Buy
40,935
+7
+0% +$136 ﹤0.01% 3099
2017
Q1 		$790K Buy
40,928
+25,729
+169% +$496K ﹤0.01% 2980
2016
Q4 		$282K Buy
+15,199
New +$290K ﹤0.01% 3451

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
First Manhattan
First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Parametric Portfolio Associates's RGNX Position: Q1 2022 in Review

Parametric Portfolio Associates reduced its Regenxbio (RGNX) stake by 22% in Q1 2022, selling an estimated $631K and leaving 82,347 shares worth $2.73M. The position accounts for ﹤0.01% of the portfolio, ranked #2250.

Parametric Portfolio Associates first reported a position in RGNX in Q4 2016 and has held it in 19 quarters since. The position peaked at $3.44M in Q4 2021. 188 funds tracked by Wall St. Rank hold RGNX as of Q1 2022.

  • Parametric Portfolio Associates held 82,347 shares of Regenxbio worth $2.73M as of Q1 2022.
  • Parametric Portfolio Associates sold 22,711 Regenxbio shares in Q1 2022, an estimated $631K.
  • Regenxbio made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2250 holding.
  • Parametric Portfolio Associates first reported a position in Regenxbio in Q4 2016 and has held it in 19 quarters since.
  • Parametric Portfolio Associates's Regenxbio position peaked at $3.44M in Q4 2021.
  • 188 funds tracked by Wall St. Rank held Regenxbio as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.